Vivo Bio Tech Reports Strong Growth Amid Liquidity Concerns in August 2025 Results
Vivo Bio Tech has announced its financial results for the quarter ending June 2025, showcasing significant year-on-year growth in Profit After Tax and record net sales. While the company improved its operating profit to interest ratio and reduced its debt-equity ratio, concerns about liquidity arise due to decreased cash reserves.
Vivo Bio Tech, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 12, 2025, indicate a notable shift in the company's evaluation, with its score rising to 8 from 5 over the past three months.The financial data reveals several positive trends for Vivo Bio Tech. The Profit After Tax (PAT) for the latest six months stands at Rs 2.40 crore, reflecting a significant year-on-year growth of 163.74%. Additionally, net sales reached a record high of Rs 12.51 crore for the quarter, showing consistent growth over the last five quarters. The company's operating profit to interest ratio has also reached its highest level in this period, at 3.65 times, indicating an improved capacity to manage interest payments. Furthermore, the debt-equity ratio has decreased to 0.69 times, suggesting a reduction in borrowing relative to equity capital.
However, the financial results also highlight some challenges. The cash and cash equivalents have dropped to Rs 1.28 crore, marking the lowest level in the last six half-yearly periods, which raises concerns about short-term liquidity.
For more insights on Vivo Bio Tech's financial performance and evaluation changes, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
